BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18632781)

  • 1. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.
    Grytten Torkildsen N; Lie SA; Aarseth JH; Nyland H; Myhr KM
    Mult Scler; 2008 Nov; 14(9):1191-8. PubMed ID: 18632781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
    Smestad C; Sandvik L; Celius EG
    Mult Scler; 2009 Nov; 15(11):1263-70. PubMed ID: 19812114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of patients with multiple sclerosis in West France.
    Leray E; Morrissey S; Yaouanq J; Coustans M; Le Page E; Chaperon J; Edan G
    Mult Scler; 2007 Aug; 13(7):865-74. PubMed ID: 17881399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in survival and cause of death in Danish patients with multiple sclerosis.
    Brønnum-Hansen H; Koch-Henriksen N; Stenager E
    Brain; 2004 Apr; 127(Pt 4):844-50. PubMed ID: 14960501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
    Lunde HMB; Assmus J; Myhr KM; Bø L; Grytten N
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):621-625. PubMed ID: 28365589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
    Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term cause-specific mortality among five-year survivors of childhood cancer.
    Cardous-Ubbink MC; Heinen RC; Langeveld NE; Bakker PJ; Voûte PA; Caron HN; van Leeuwen FE
    Pediatr Blood Cancer; 2004 Jun; 42(7):563-73. PubMed ID: 15127410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.
    Grytten N; Glad SB; Aarseth JH; Nyland H; Midgard R; Myhr KM
    Neurology; 2006 Jan; 66(2):182-6. PubMed ID: 16434650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
    Sandi D; Zsiros V; Füvesi J; Kincses ZT; Fricska-Nagy Z; Lencsés G; Vécsei L; Bencsik K
    J Neurol Sci; 2016 Aug; 367():329-32. PubMed ID: 27423613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival in disseminated sclerosis in Denmark. A nation-wide study of the period 1948-1986].
    Brønnum-Hansen H; Koch-Henriksen NJ; Hyllested K
    Ugeskr Laeger; 1995 Dec; 157(51):7131-5. PubMed ID: 8545927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; De Keyser J
    Mult Scler; 2008 Jul; 14(6):799-803. PubMed ID: 18573840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.
    Gorman MP; Healy BC; Polgar-Turcsanyi M; Chitnis T
    Arch Neurol; 2009 Jan; 66(1):54-9. PubMed ID: 19139299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.
    Theander E; Manthorpe R; Jacobsson LT
    Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register.
    Lie SA; Engesaeter LB; Havelin LI; Gjessing HK; Vollset SE
    Acta Orthop Scand; 2000 Feb; 71(1):19-27. PubMed ID: 10743987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-up.
    Dawson SI; Willis J; Florkowski CM; Scott RS
    Diabetes Res Clin Pract; 2008 Apr; 80(1):16-23. PubMed ID: 18329124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.